Adjuvant Pembrolizumab After Radiation Therapy for Lung-Intact Malignant Pleural Mesothelioma
Status:
Not yet recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to assess the safety of pembrolizumab (also
called MK-3475) after radiation therapy (with or without surgery and/or chemotherapy) in
patients with MPM.